insur properti casualti unit state america
updat ep forecast follow result manag
withdrawn guidanc mid-singl digit greater organ growth double-
digit free cash flow growth near term due pandem
also halt share repurchas temporarili although reaffirm
commit acquisit expect close despit
rescind organ growth guidanc manag remind investor
revenu base highli recur encompass non-discretionari servic like
 insur brokerag accordingli forecast flat organ revenu
year despit recess estim
respect said discretionari data analyt retir
segment alreadi saw headwind pandem expect
underli declin segment remaind year although
organ growth come pressur still expect margin
improv cost reduct includ recent announc base
salari reduct permit expans continu ep
forecast declin respect
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
million except per share data
incom continu oper tax
adjust oper incom ex charg amort
adjust net incom attribut
incom continu oper
net incom attribut
acquisitions/divestitur
pension
million except per share data
statement flow
net provid oper activ
acquisit busi net cash
net use invest activ
net use financ activit
begin period
increar decrear equival
end period
million except per share data
amount share repurchar
ep histor averagesdu torec rerat strong price
pend acquisit creat
pend acquisit creat
largest broker world
largest broker world measur
term growth proposit cost synergi
accret high-teen
accret risk divestitur
next year deal undergo
growth increas sharehold
growth increas sharehold
return aon success shift focu
high-margin high-growth busi
andw expect focu remain
acquisit near term risk organ
growth due recessionari environ
view descript risk reward theme
price swiftglob econom recoveri
accret acquisit boost
expect deal drive signic
revenu synergi valuat previou
ep compound-annual-growth-rate organ
growth constrain near term due
recess recoveri
price reacceler
side pandem wltw
acquisitionclos top line
achiev target cost synergi ep
accret valuat histor
issu price declin econom
recess reduc organ growth
expect challeng close integr
deal target synergi andep
accret achiev valuat contract
histor averag
china india
view explan region hierarchi
research highest favor quintil
expans upsid acquisit
restructur issu lift posit
 price materi econom
slowdown slower organ growth margin
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
